GB1351532A - Prostenoic acid derivatives - Google Patents

Prostenoic acid derivatives

Info

Publication number
GB1351532A
GB1351532A GB4380771A GB4380771A GB1351532A GB 1351532 A GB1351532 A GB 1351532A GB 4380771 A GB4380771 A GB 4380771A GB 4380771 A GB4380771 A GB 4380771A GB 1351532 A GB1351532 A GB 1351532A
Authority
GB
United Kingdom
Prior art keywords
sept
acid derivatives
alkyl
prostaglandins
prostenoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4380771A
Inventor
K Sakai
T Yusa
M Sasaki
S Amemiya
M Yamazaki
K Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP45082238A external-priority patent/JPS514990B1/ja
Priority claimed from JP8480070A external-priority patent/JPS4928749B1/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of GB1351532A publication Critical patent/GB1351532A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1351532 Compositions comprising prostaglandins SANKYO CO Ltd 20 Sept 1971 [19 Sept 1970 28 Sept 1970] 43807/71 Heading A5B [Also in Division C2] Pharmaceutical compositions, suitable for parenteral administration, contain novel prostaglandins of the formula: wherein A is C 1-10 alkylene, R<SP>1</SP> is C 1-10 alkyl, R<SP>2</SP> is H or C 1-5 alkyl and the cyclopentylene is a group of the formulae: wherein R<SP>3</SP> is H or 2-tetrahydropyranyl; or alklali or alkaline earth metal salts thereof when R<SP>2</SP> is H and pharmaceutical carriers or diluents, and if desired, known prostaglandens. The compounds possess uterine and ileum contracting activities.
GB4380771A 1970-09-19 1971-09-20 Prostenoic acid derivatives Expired GB1351532A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP45082238A JPS514990B1 (en) 1970-09-19 1970-09-19
JP8480070A JPS4928749B1 (en) 1970-09-28 1970-09-28

Publications (1)

Publication Number Publication Date
GB1351532A true GB1351532A (en) 1974-05-01

Family

ID=26423252

Family Applications (2)

Application Number Title Priority Date Filing Date
GB4380771A Expired GB1351532A (en) 1970-09-19 1971-09-20 Prostenoic acid derivatives
GB4381071A Expired GB1351533A (en) 1970-09-19 1971-09-20 Oxoprostenoic acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4381071A Expired GB1351533A (en) 1970-09-19 1971-09-20 Oxoprostenoic acid derivatives

Country Status (7)

Country Link
BE (2) BE772837A (en)
CA (2) CA951723A (en)
DE (2) DE2147316A1 (en)
FR (2) FR2106631B1 (en)
GB (2) GB1351532A (en)
NL (2) NL7112746A (en)
SE (2) SE375090B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887587A (en) * 1972-04-17 1975-06-03 Pfizer Synthesis of prostaglandins of the one-series

Also Published As

Publication number Publication date
FR2106631B1 (en) 1975-08-01
GB1351533A (en) 1974-05-01
DE2147315A1 (en) 1972-03-23
BE772837A (en) 1972-01-17
CA974987A (en) 1975-09-23
NL7112746A (en) 1972-03-21
FR2106631A1 (en) 1972-05-05
NL7112804A (en) 1972-03-21
BE772836A (en) 1972-01-17
FR2106630A1 (en) 1972-05-05
CA951723A (en) 1974-07-23
SE375089B (en) 1975-04-07
SE375090B (en) 1975-04-07
FR2106630B1 (en) 1975-08-01
DE2147316A1 (en) 1972-05-25

Similar Documents

Publication Publication Date Title
GB1315608A (en) Pyrimidine carboxylic acids
GB1355147A (en) Oxoprostanoic acid derivatives
IE41440L (en) Thiatetracyclines
GB1351532A (en) Prostenoic acid derivatives
GB1410853A (en) Pharmaceutically useful prostaglandin derivatives
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
GB1233268A (en)
GB1316894A (en) Benzimidazole derivatives
GB1271519A (en) Improvements in or relating to derivatives of phloroglucinol
GB1342760A (en) Substituted phthalazines
GB1420758A (en) Anti-ulcer compositions
IE35223B1 (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
GB1356406A (en) Indole derivatives
GB1342232A (en) Aryliminothiazolidines a process for their preparation and their use as acaricides
GB1369888A (en) Substituted amidines
GB1268259A (en) Imidazoline derivatives
GB1422722A (en) Acrylic acid derivatives
GB1422223A (en) Isothiocyanates
GB1277993A (en) Amebicidal compositions and processes
GB1451043A (en) Biologicylly acitve compounds and compositions
GB1321361A (en) Preparation of pyrimidylmethyl-pyridinium derivatives
IE41481L (en) 1, 4-benzodiazepine derivatives.
GB1480892A (en) 3-nitropyrazole derivatives
GB1363640A (en) Esters of 2,2-diphenyl - cyclopropane - carboxylic acids
GB1521747A (en) Prostaglandin analogues

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees